Research Article
Use of Antiasthmatic Drugs during Pregnancy after the First Trimester and Maternal and Neonatal Outcomes
Table 1
Overview of antiasthmatic drugs prescribed to women within one year before delivery.
| Drug group | Drug name | ATC-code | Number of women |
| Inhaled short-acting β-agonist | Salbutamol | R03AC02 | 2099 | Terbutaline | R03AC03 | 5284 |
| Inhaled long-acting β-agonist | Salmeterol | R03AC12 | 102 | Formoterol | R03AC13 | 503 | Indacaterol | R03AC18 | 1 |
| Inhaled combined short-acting β-agonist with other drug | Salbutamol + ipratropium | R03AK04 | 39 |
| Inhaled combined long-acting β-agonist with corticosteroid | Salmeterol + fluticasone | R03AK06 | 535 | Formoterol + budesonide | R03AK07 | 1594 |
| Inhaled corticosteroid | Beclometazone | R03BA01 | 75 | Budesonide | R03BA02 | 4175 | Fluticasone | R03BA05 | 220 | Mometasone | R03BA07 | 23 |
| Anticholinergics | Ipratropium | R03BB01 | 31 | Thiotropium | R03BB04 | 7 |
| Antiallergics | Cromoglicic acid | R03BC01 | 19 |
| Oral adrenergics | Ephedrine | R03CA02 | 1 | Salbutamol | R03CC02 | 38 | Terbutaline | R03CC03 | 2474 |
| Xanthines | Choline theophyllinate | R03DA02 | 10 | Theophylline | R03DA04 | 12 |
| Leuotriene receptor antagonist | Montelukast | R03DC03 | 231 |
| Antibody | Omalizumab | R03DX05 | 1 |
|
|